Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT
2 other identifiers
interventional
190
1 country
1
Brief Summary
The purpose of this study is to assess new low radiation dose techniques for clinical PET/CT scans through intra-individual comparison between a clinical, standard dose scan and a low-dose scan, completed within one week of each other.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 21, 2015
CompletedFirst Submitted
Initial submission to the registry
February 22, 2018
CompletedFirst Posted
Study publicly available on registry
May 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJanuary 18, 2024
January 1, 2024
9.5 years
February 22, 2018
January 16, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Image quality
assessed by blinded readers
through study completion, on average 2-5 years
Secondary Outcomes (3)
Artifacts
through study completion, on average 2-5 years
Lesion detectability
through study completion, on average 2-5 years
Image noise
through study completion, on average 2-5 years
Study Arms (6)
Sub-Study A
EXPERIMENTALPatients receive PET/CT scan on Gemini Astonish PET/CT
Sub-Study B
EXPERIMENTALPatients receive PET/CT scan on Biograph mCT
Sub-Study C
EXPERIMENTALPatients receive PET/CT scan on Discovery PET/CT
Sub-Study D
EXPERIMENTALPatients receive PET/CT scan on Vereos 128 digital PET/CT
Sub-Study E
EXPERIMENTALPatients receive lower radiation dose on Vereos 128 digital PET/CT
Sub-Study F
EXPERIMENTALPatients receive PET/SCAN using system that did not show equivalence in Sub-Study A-C
Interventions
13 mCi 18F-FDG dose
5 mCi 18F-FDG dose
We plan for the possibility that one of the three-Sub-Studies (A-B) would not demonstrate equivalency, and we would then perform a modified protocol in which the SOC dosing is compared to a lower and higher dose than originally tested.
Eligibility Criteria
You may qualify if:
- Male and female patients greater than or equal to 18 years of age
- Patients scheduled for a standard of care PET/CT scan
- For female patients of child-bearing potential, the OSUWMC requirements for receiving the standard of care PET imaging agent and CT examination needs to be met
You may not qualify if:
- Participants who are pregnant or lactating
- Prisoners
- Participants incapable of giving informed consent
- Patients unable to lie flat on the scanner for extended periods of time
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Cincinnatilead
- National Cancer Institute (NCI)collaborator
- Ohio Third Frontiercollaborator
Study Sites (1)
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43221, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael V Knopp, MD, PhD
Ohio State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 22, 2018
First Posted
May 9, 2018
Study Start
July 21, 2015
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
January 18, 2024
Record last verified: 2024-01